These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30131390)
1. Increased β-Cell Workload Modulates Proinsulin-to-Insulin Ratio in Humans. Mezza T; Ferraro PM; Sun VA; Moffa S; Cefalo CMA; Quero G; Cinti F; Sorice GP; Pontecorvi A; Folli F; Mari A; Alfieri S; Giaccari A Diabetes; 2018 Nov; 67(11):2389-2396. PubMed ID: 30131390 [TBL] [Abstract][Full Text] [Related]
2. Proinsulin levels in patients with pancreatic diabetes are associated with functional changes in insulin secretion rather than pancreatic beta-cell area. Breuer TG; Menge BA; Banasch M; Uhl W; Tannapfel A; Schmidt WE; Nauck MA; Meier JJ Eur J Endocrinol; 2010 Oct; 163(4):551-8. PubMed ID: 20679359 [TBL] [Abstract][Full Text] [Related]
3. Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans. Seaquist ER; Kahn SE; Clark PM; Hales CN; Porte D; Robertson RP J Clin Invest; 1996 Jan; 97(2):455-60. PubMed ID: 8567967 [TBL] [Abstract][Full Text] [Related]
4. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy. Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749 [TBL] [Abstract][Full Text] [Related]
5. The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes. Retnakaran R; Hanley AJ; Sermer M; Zinman B Diabetes Care; 2005 Nov; 28(11):2710-5. PubMed ID: 16249544 [TBL] [Abstract][Full Text] [Related]
6. Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes. Vauhkonen IK; Niskanen LK; Mykkänen L; Haffner SM; Uusitupa MI; Laakso M Eur J Endocrinol; 2000 Aug; 143(2):251-60. PubMed ID: 10913945 [TBL] [Abstract][Full Text] [Related]
7. Are insulin and proinsulin independent risk markers for premature coronary artery disease ? Katz RJ; Ratner RE; Cohen RM; Eisenhower E; Verme D Diabetes; 1996 Jun; 45(6):736-41. PubMed ID: 8635646 [TBL] [Abstract][Full Text] [Related]
8. The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma. Koivisto VA; Yki-Järvinen H; Hartling SG; Pelkonen R J Clin Endocrinol Metab; 1986 Nov; 63(5):1117-20. PubMed ID: 3020076 [TBL] [Abstract][Full Text] [Related]
10. Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients. Derosa G; Ragonesi PD; Carbone A; Fogari E; Bianchi L; Bonaventura A; Romano D; Cicero AF; Maffioli P Diabetes Technol Ther; 2012 Jun; 14(6):475-84. PubMed ID: 22512264 [TBL] [Abstract][Full Text] [Related]
11. Effect of pancreas transplantation and immunosuppression on proinsulin secretion. Christiansen E; Røder M; Tibell A; Hales CN; Madsbad S Diabet Med; 1998 Sep; 15(9):739-46. PubMed ID: 9737802 [TBL] [Abstract][Full Text] [Related]
12. The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects. Mykkänen L; Haffner SM; Hales CN; Rönnemaa T; Laakso M Diabetes; 1997 Dec; 46(12):1990-5. PubMed ID: 9392485 [TBL] [Abstract][Full Text] [Related]
13. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. Larsson H; Ahrén B J Clin Endocrinol Metab; 1999 Jun; 84(6):2068-74. PubMed ID: 10372712 [TBL] [Abstract][Full Text] [Related]
14. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients. van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393 [TBL] [Abstract][Full Text] [Related]
15. The effect of different volumes of high-intensity interval training on proinsulin in participants with the metabolic syndrome: a randomised trial. Ramos JS; Dalleck LC; Borrani F; Mallard AR; Clark B; Keating SE; Fassett RG; Coombes JS Diabetologia; 2016 Nov; 59(11):2308-2320. PubMed ID: 27480182 [TBL] [Abstract][Full Text] [Related]
16. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction. Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514 [TBL] [Abstract][Full Text] [Related]
17. Development of a feline proinsulin immunoradiometric assay and a feline proinsulin enzyme-linked immunosorbent assay (ELISA): a novel application to examine beta cell function in cats. Kley S; Caffall Z; Tittle E; Ferguson DC; Hoenig M Domest Anim Endocrinol; 2008 Apr; 34(3):311-8. PubMed ID: 17949938 [TBL] [Abstract][Full Text] [Related]
18. Proinsulin/insulin ratio as a predictor of insulin resistance and B-cell dysfunction in obese Egyptians ((insulin resistance & B-cell dysfunction in obese Egyptians)). El Shabrawy AM; Elbana KA; Abdelsalam NM Diabetes Metab Syndr; 2019; 13(3):2094-2096. PubMed ID: 31235142 [TBL] [Abstract][Full Text] [Related]
19. Modulation of proinsulin messenger RNA after partial pancreatectomy in rats. Relationships to glucose homeostasis. Orland MJ; Chyn R; Permutt MA J Clin Invest; 1985 Jun; 75(6):2047-55. PubMed ID: 3891788 [TBL] [Abstract][Full Text] [Related]
20. Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes. Ahrén B; Pacini G; Tura A; Foley JE; Schweizer A Horm Metab Res; 2007 Nov; 39(11):826-9. PubMed ID: 17992639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]